Chemotherapy regimen based on sorafenib combined with 5-FU on HIF-1α and VEGF expression and survival in advanced gastric cancer patients

The present study investigated the effect of combined sorafenib chemotherapy on hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) expression and survival time of patients with advanced gastric cancer. From January 2010 to December 2011, 92 patients diagnosed with adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Ronghui, Yong, Hongmei, Xia, Yunhong, Xie, Qingsong, Gao, Guangyi, Zhou, Xueyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403399/
https://www.ncbi.nlm.nih.gov/pubmed/28454454
http://dx.doi.org/10.3892/ol.2017.5769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403399/
https://www.ncbi.nlm.nih.gov/pubmed/28454454
http://dx.doi.org/10.3892/ol.2017.5769

Ejemplares similares